Baltimore Washington Medical Center INC.

Baltimore Washington Medical Center INC. was paid $2.35M by Medicaid between Jan 2018 and Nov 2024, across 86 billing codes. Its largest line is G0378, Hospital observation service, per hour — 41% of everything it billed.

33Billing provider infoBALTIMORE WASHINGTON MEDICAL CENTER INC.
GLEN BURNIE, MD 21061

33aNPI1124016696assigned 10/10/2005

33bProvider typeCritical Care Medicine (Internal Medicine) Physician

28Total paid$2.35M

24GClaims103,756

24DCodes billed86

24AFirst – last monthJan 2018 – Nov 2024

Compared with peers

Next to other Critical Care Medicine (Internal Medicine) Physician providers in Maryland

Rank by total paid#2 of 26

Median peer was paid$114K

This provider vs. median21×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	22,961	$67K
2019	19,803	$246K
2020	12,718	$457K
2021	15,023	$489K
2022	13,649	$418K
2023	11,831	$432K
2024incomplete	7,771	$242K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0378	Hospital observation service, per hour	41%	1,804	1,600	$974K
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	26%	6,977	6,245	$609K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	18%	3,323	3,016	$417K
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	7.6%	3,266	2,916	$179K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	3.9%	5,930	4,951	$91K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	2,104	1,787	$15K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	56	12	$10K
78815	Positron emission tomography (PET) for limited area imaging	<1%	12	12	$10K
93880		<1%	113	111	$7K
80053	Comprehensive metabolic panel	<1%	10,599	8,644	$5K
71046	Radiologic examination, chest; 2 views	<1%	3,696	3,372	$4K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	11,843	9,018	$4K

74 more codes

70450	Computed tomography, head or brain; without contrast material	<1%	2,126	$4K
84484		<1%	4,427	$3K
93922		<1%	147	$3K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	414	$2K
97161		<1%	305	$2K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	95	$2K
93971		<1%	56	$1K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	642	$1K
71045	Radiologic examination, chest; single view	<1%	1,515	$1K
71275	Computed tomographic angiography, chest, with contrast material	<1%	67	$923.08
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	644	$774.57
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	182	$652.86
81001		<1%	4,150	$572.42
80048	Basic metabolic panel (calcium, ionized)	<1%	1,858	$481.39
83735		<1%	6,935	$448.18
83690		<1%	2,196	$400.46
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	126	$380.70
73562		<1%	12	$314.48
83880		<1%	670	$293.85
J7030	Infusion, normal saline solution , 1000 cc	<1%	3,878	$275.55
83605		<1%	218	$273.67
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	16	$250.26
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	118	$230.20
84443	Thyroid stimulating hormone (TSH)	<1%	119	$207.53
87086	Culture, bacterial; quantitative colony count, urine	<1%	598	$189.34
85610		<1%	2,697	$180.05
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	1,018	$171.86
84703		<1%	865	$130.81
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	208	$128.82
85730		<1%	274	$106.91
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	2,500	$89.53
80061	Lipid panel	<1%	119	$82.52
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	175	$81.10
J7050	Infusion, normal saline solution, 250 cc	<1%	1,312	$81.06
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	1,182	$61.47
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	750	$60.37
J2704	Injection, propofol, 10 mg	<1%	1,512	$55.19
J7120	Ringers lactate infusion, up to 1000 cc	<1%	1,552	$51.68
J2270	Injection, morphine sulfate, up to 10 mg	<1%	890	$49.50
72100		<1%	12	$43.45
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	1,733	$41.36
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	1,005	$29.04
J3475	Injection, magnesium sulfate, per 500 mg	<1%	268	$27.22
86850		<1%	104	$26.06
84100		<1%	293	$22.87
87186		<1%	102	$22.18
J1644	Injection, heparin sodium, per 1000 units	<1%	728	$15.22
85379		<1%	125	$11.48
86901		<1%	106	$8.69
86900		<1%	106	$8.69
J2060	Injection, lorazepam, 2 mg	<1%	135	$6.11
87081		<1%	12	$5.20
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	207	$2.71
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	50	$1.29
J2765	Injection, metoclopramide hcl, up to 10 mg	0%	45	$0.00
82550		0%	13	$0.00
87040		0%	13	$0.00
94760		0%	81	$0.00
J0690	Injection, cefazolin sodium, 500 mg	0%	47	$0.00
85027		0%	47	$0.00
J0696	Injection, ceftriaxone sodium, per 250 mg	0%	102	$0.00
87205		0%	14	$0.00
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	0%	12	$0.00
87070		0%	12	$0.00
87077		0%	42	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	27	$0.00
J1170	Injection, hydromorphone, up to 4 mg	0%	16	$0.00
80050	General health panel	0%	14	$0.00
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	0%	1,721	$0.00
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	0%	64	$0.00
J1650	Injection, enoxaparin sodium, 10 mg	0%	18	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	90	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	89	$0.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMCCONE, WILLIAM (SR VP FINANCE)